SCHEMBL29495910

SCHEMBL29495910

CCc1nc(N)ccc1-c1cccc2ccc(N3CCCOCC3)nc12

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.49
▸ PIM1 P11309 1/20 0.43
▸ PIM2 Q9P1W9 1/20 0.43
▸ HTR3A P46098 1/20 0.41
▸ MCHR1 Q99705 1/20 0.41
▸ CCNC P24863 1/20 0.40
▸ CDK8 P49336 1/20 0.40
▸ CNR2 P34972 3/20 0.40
▸ ADRB1 P08588 1/20 0.39
▸ PIK3CA P42336 2/20 0.37
▸ MTOR P42345 2/20 0.37
▸ SHMT2 P34897 3/20 0.37
▸ ATR Q13535 2/20 0.36
▸ ATRIP Q8WXE1 2/20 0.36
▸ PRMT5 O14744 1/20 0.36
▸ WDR77 Q9BQA1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22969511 1.00 GAA (0.49) GAAPIM1PIM2HTR3AMCHR1
SCHEMBL29495731 0.97 GAA (0.52) GAAPIM1PIM2HTR3AMCHR1
SCHEMBL22969615 0.97 GAA (0.52) GAAPIM1PIM2HTR3AMCHR1
SCHEMBL22969580 0.90 HTR3A (0.47) GAAHTR3AMCHR1ADRB1
SCHEMBL29495986 0.90 HTR3A (0.47) GAAHTR3AMCHR1ADRB1
SCHEMBL29496062 0.84 GAA (0.48) GAAPIM1PIM2HTR3ACCNC
SCHEMBL22969277 0.83 SHMT2 (0.42) GAACCNCCDK8PIK3CAMTOR
SCHEMBL29495961 0.83 SHMT2 (0.42) GAACCNCCDK8PIK3CAMTOR
SCHEMBL22969399 0.82 HTR3A (0.42) GAAHTR3AMCHR1CNR2ADRB1
SCHEMBL29495813 0.82 HTR3A (0.42) GAAHTR3AMCHR1CNR2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114269730-A 5-heteroaryl-pyridin-2-amine compounds as neuropeptide FF receptor antagonists 多曼治疗学公司 2022-04-01 — — CN claimed
CN-114269730-A 5-heteroaryl-pyridin-2-amine compounds as neuropeptide FF receptor antagonists 多曼治疗学公司 2022-04-01 — — CN disclosed
Send feedback